Prohance

Product manufactured by Bracco Diagnostics Inc

Application Nr Approved Date Route Status External Links
NDA021489 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Prohance Multipack Is A Gadolinium-Based Paramagnetic Mri Contrast Agent Indicated For Intravenous Use To Visualize: Lesions With Abnormal Vascularity In The Brain (Intracranial Lesions), Spine And Associated Tissues In Adults And Pediatric Patients Over 2 Years Of Age ( 1.1 ) Lesions In The Head And Neck In Adults ( 1.2 ) 1.1 Mri Of The Central Nervous System (Cns) Prohance Is Indicated For Use In Magnetic Resonance Imaging (Mri) In Adults And Pediatric Patients Over 2 Years Of Age To Visualize Lesions With Abnormal Vascularity In The Brain (Intracranial Lesions), Spine And Associated Tissues. 1.2 Mri Of Extracranial/extraspinal Tissues Prohance Is Indicated For Use In Mri In Adults To Visualize Lesions In The Head And Neck.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Gadoteridol GADOTERIDOL ZINC22016981

Comments